Screening for Brain Metastases in HER2+ Breast Cancer

Video

Andrew Brenner, MD, explains when physicians should screen patients with HER2+ breast cancer for brain metastases.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
4 experts in this video
4 experts in this video
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Patients with node-negative disease who are older and have comorbidities may not be suitable to receive CDK4/6 inhibitors.